Literature DB >> 28463231

Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction.

Christa F Gaskill1, Erica J Carrier1, Jonathan A Kropski1, Nathaniel C Bloodworth2, Swapna Menon3, Robert F Foronjy4, M Mark Taketo5, Charles C Hong1,6, Eric D Austin7, James D West1, Anna L Means8, James E Loyd1, W David Merryman2, Anna R Hemnes1, Stijn De Langhe9, Timothy S Blackwell1, Dwight J Klemm10,11, Susan M Majka1,12.   

Abstract

Pulmonary vascular disease is characterized by remodeling and loss of microvessels and is typically attributed to pathological responses in vascular endothelium or abnormal smooth muscle cell phenotypes. We have challenged this understanding by defining an adult pulmonary mesenchymal progenitor cell (MPC) that regulates both microvascular function and angiogenesis. The current understanding of adult MPCs and their roles in homeostasis versus disease has been limited by a lack of genetic markers with which to lineage label multipotent mesenchyme and trace the differentiation of these MPCs into vascular lineages. Here, we have shown that lineage-labeled lung MPCs expressing the ATP-binding cassette protein ABCG2 (ABCG2+) are pericyte progenitors that participate in microvascular homeostasis as well as adaptive angiogenesis. Activation of Wnt/β-catenin signaling, either autonomously or downstream of decreased BMP receptor signaling, enhanced ABCG2+ MPC proliferation but suppressed MPC differentiation into a functional pericyte lineage. Thus, enhanced Wnt/β-catenin signaling in ABCG2+ MPCs drives a phenotype of persistent microvascular dysfunction, abnormal angiogenesis, and subsequent exacerbation of bleomycin-induced fibrosis. ABCG2+ MPCs may, therefore, account in part for the aberrant microvessel function and remodeling that are associated with chronic lung diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28463231      PMCID: PMC5451236          DOI: 10.1172/JCI88629

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  100 in total

1.  NG2 proteoglycan expression by pericytes in pathological microvasculature.

Authors:  Ugur Ozerdem; Edward Monosov; William B Stallcup
Journal:  Microvasc Res       Date:  2002-01       Impact factor: 3.514

Review 2.  Pivotal role of pericytes in kidney fibrosis.

Authors:  Yujiro Kida; Jeremy S Duffield
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-07       Impact factor: 2.557

3.  Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration.

Authors:  Susan M Majka; Kathyjo A Jackson; Kirsten A Kienstra; Mark W Majesky; Margaret A Goodell; Karen K Hirschi
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

4.  The elusive source of myofibroblasts: problem solved?

Authors:  Jeremy S Duffield
Journal:  Nat Med       Date:  2012-08       Impact factor: 53.440

5.  Associated pulmonary arterial hypertension in connective tissue diseases.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2011-04

6.  Endothelial cell-derived non-canonical Wnt ligands control vascular pruning in angiogenesis.

Authors:  Claudia Korn; Beate Scholz; Junhao Hu; Kshitij Srivastava; Jessica Wojtarowicz; Tabea Arnsperger; Ralf H Adams; Michael Boutros; Hellmut G Augustin; Iris Augustin
Journal:  Development       Date:  2014-04       Impact factor: 6.868

7.  Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension.

Authors:  D Case; D Irwin; C Ivester; J Harral; K Morris; M Imamura; M Roedersheimer; A Patterson; M Carr; M Hagen; M Saavedra; J Crossno; K A Young; E C Dempsey; F Poirier; J West; S Majka
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-09-01       Impact factor: 5.464

8.  Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.

Authors:  Masahiko Oka; Noriyuki Homma; Laimute Taraseviciene-Stewart; Kenneth G Morris; Donatas Kraskauskas; Nana Burns; Norbert F Voelkel; Ivan F McMurtry
Journal:  Circ Res       Date:  2007-03-01       Impact factor: 17.367

9.  Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.

Authors:  Carl Atkinson; Susan Stewart; Paul D Upton; Rajiv Machado; Jennifer R Thomson; Richard C Trembath; Nicholas W Morrell
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

10.  Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions.

Authors:  Sergei A Kuznetsov; Mahesh H Mankani; Paolo Bianco; Pamela G Robey
Journal:  Stem Cell Res       Date:  2008-08-12       Impact factor: 2.020

View more
  18 in total

1.  Inactivation of Tsc2 in Abcg2 lineage-derived cells drives the appearance of polycystic lesions and fibrosis in the adult kidney.

Authors:  Leslie S Gewin; Megan E Summers; Julie W Harral; Christa F Gaskill; Stellor Nlandu Khodo; Surekha Neelisetty; Timothy M Sullivan; Katharina Hopp; J Jeffrey Reese; Dwight J Klemm; Valentina Kon; Kevin C Ess; Wei Shi; Susan M Majka
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

2.  The elephant in the lung: Integrating lineage-tracing, molecular markers, and single cell sequencing data to identify distinct fibroblast populations during lung development and regeneration.

Authors:  Matthew Riccetti; Jason J Gokey; Bruce Aronow; Anne-Karina T Perl
Journal:  Matrix Biol       Date:  2020-05-19       Impact factor: 11.583

3.  Exploring New Therapeutic Pathways in Pulmonary Hypertension. Metabolism, Proliferation, and Personalized Medicine.

Authors:  M Patricia George; Mark T Gladwin; Brian B Graham
Journal:  Am J Respir Cell Mol Biol       Date:  2020-09       Impact factor: 6.914

4.  Mapping cardiopulmonary dynamics within the microvasculature of the lungs using dissolved 129Xe MRI.

Authors:  Peter J Niedbalski; Elianna A Bier; Ziyi Wang; Matthew M Willmering; Bastiaan Driehuys; Zackary I Cleveland
Journal:  J Appl Physiol (1985)       Date:  2020-06-18

5.  Pericytes as novel targets for HIV/SIV infection in the lung.

Authors:  Sarah E Stephenson; Carole L Wilson; Nell G Bond; Amitinder Kaur; Xavier Alvarez; Cecily C Midkiff; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-09       Impact factor: 5.464

6.  Pathologic Fibroblasts in Idiopathic Subglottic Stenosis Amplify Local Inflammatory Signals.

Authors:  Robert J Morrison; Nicolas-George Katsantonis; Kevin M Motz; Alexander T Hillel; C Gaelyn Garrett; James L Netterville; Christopher T Wootten; Susan M Majka; Timothy S Blackwell; Wonder P Drake; Alexander Gelbard
Journal:  Otolaryngol Head Neck Surg       Date:  2018-10-16       Impact factor: 3.497

7.  GBT1118, a compound that increases the oxygen affinity of hemoglobin, improves survival in murine hypoxic acute lung injury.

Authors:  Nathan D Putz; Ciara M Shaver; Kobina Dufu; Chien-Ming Li; Qing Xu; Athiwat Hutchaleelaha; Josh Lehrer-Graiwer; Susan M Majka; Lorraine B Ware; Julie A Bastarache
Journal:  J Appl Physiol (1985)       Date:  2017-12-14

8.  WNT Signalling in Lung Physiology and Pathology.

Authors:  Yan Hu; Chiara Ciminieri; Qianjiang Hu; Mareike Lehmann; Melanie Königshoff; Reinoud Gosens
Journal:  Handb Exp Pharmacol       Date:  2021

Review 9.  Wnt signaling in lung development, regeneration, and disease progression.

Authors:  Cody J Aros; Carla J Pantoja; Brigitte N Gomperts
Journal:  Commun Biol       Date:  2021-05-20

10.  Balanced Wnt/Dickkopf-1 signaling by mesenchymal vascular progenitor cells in the microvascular niche maintains distal lung structure and function.

Authors:  Megan E Summers; Bradley W Richmond; Jonathan A Kropski; Sarah A Majka; Julie A Bastarache; Antonis K Hatzopoulos; Jeffery Bylund; Moumita Ghosh; Irina Petrache; Robert F Foronjy; Patrick Geraghty; Susan M Majka
Journal:  Am J Physiol Cell Physiol       Date:  2020-10-21       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.